Head-to-head · WeighScore
Aurelius Health Group vs Sunlight.com
By GLP-1 ScorecardUpdated
Score comparison
Sunlight.com has the higher recorded score — 83.7/100 to 60.8/100.
Sunlight.com grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Sunlight advertises low flat monthly rates and now names its pharmacy network. Its public pages leave enough uncertainty about the selected payment and shipping timeline that the final plan needs a closer look.
Before you choose
Aurelius Health Group does not publish a semaglutide price, so its Aurelius Health Group review sets out what it does disclose, while the Sunlight.com review explains the conditions attached to Sunlight.com's figure. The semaglutide cost page compares published rates across the field. Ask Aurelius Health Group for a written total before treating either one as the cheaper choice.
If neither one fits, Aurelius Health Group vs Trimi and boostAGErx vs Sunlight.com compare each of them with another graded program, and the list of alternatives to Aurelius Health Group ranks the programs closest to Aurelius Health Group on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Aurelius Health Group | Sunlight.com |
|---|---|---|
| WeighScore | 60.8/100 | 83.7/100 |
| Grade | C | B |
| Site position | #340 | #22 |
| Semaglutide | No separate semaglutide price published | From $78/month advertised (early Black Friday banner); confirm charge and term |
| Tirzepatide | No separate tirzepatide price published | From $139/month advertised (early Black Friday banner); confirm charge and term |
| Coverage | Confirm program availability in your state | Nationwide platform; treatment availability varies by state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes the introductory and recurring program prices
- Lists consultations and ongoing monitoring as part of the program
- Publishes a cancellation cutoff before the next bill
What to consider
- The public price does not identify the selected prescription and usable supply
- Cancellation notice is due at least 72 hours before the next bill
- The summary and detailed policy differ on the scope of medical-disqualification refunds
Strengths
- Public FAQ advertises semaglutide from $78 and tirzepatide from $139 monthly
- Names six pharmacy partners and the Lion MD clinical network
- Medication if approved, telehealth visits and shipping are included
What to consider
- Exact payment and any prepaid commitment were not verified without completing intake; the advertised rate fell from $88 and $157 in October and sits under a seasonal banner
- Landing-page shipping claims differ from the FAQ’s within-seven-business-days statement
- Oral options appear in marketing but no specific oral GLP-1 offer was confirmed
- Refunds are unavailable once a prescription is written and sent to the pharmacy
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.